Checkpoint Therapeutics (CKPT) Stock Highlights

3.75 | +11.28%

2024-12-21 06:34:33

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP).

Statistics

Range Today

3.33 3.76

Volume Today 2.24M

Range 1 Year

1.38 4.5

Volume 1 Year 172.35M

Range 3 Year

1.3 32.71

Volume 3 Year 278.05M

Range 10 Year

1.3 150

Volume 10 Year 326.6M

Highlights

Market Capitalization 151.71M (small)

Floating Shares 34.79M

Current Price 3.75

Price To Earnings -2.05

Price To Revenue 1.88K

Earnings Per Share -1.71

Payout Ratio 0%

Performance

Latest +11.28%

1 Month +10.62%

3 Months +52.44%

6 Months +87.5%

1 Year +104.92%

3 Years -86.89%

5 Years -70.47%

10 Years -92.5%

Benchmarks

Market Capitalization

290 / 368

Gross Profits

0 / 278

Total Revenue

271 / 300

Total Rank

83 / 368

Free Cashflow

178 / 352

Performance 5 years

202 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.